Samina Khan

Net worth: 7 M $ as of 2023-09-29

59 year

Consumer Services

Health Technology

Active connections

Name	Gender	Age	Linked companies	Collaboration
J. Huff	M	70	REATA PHARMACEUTICALS, INC.	2 years
Michael McDonnell	M	60	REATA PHARMACEUTICALS, INC.	1 years
Fearghas Carruthers	M	-	REATA PHARMACEUTICALS, INC.	1 years
Michael Dambach	M	-	REATA PHARMACEUTICALS, INC.	1 years
Robin Kramer	M	-	REATA PHARMACEUTICALS, INC.	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Manmeet Singh Soni	M	46	REATA PHARMACEUTICALS, INC.	4 years
Vineet R. Jindal	M	-	REATA PHARMACEUTICALS, INC.	5 years
W. Wigley	M	-	REATA PHARMACEUTICALS, INC.	21 years
James E. Bass	M	65	REATA PHARMACEUTICALS, INC.	6 years
Joel Proksch	M	-	REATA PHARMACEUTICALS, INC.	9 years
Shamim Ruff	F	64	REATA PHARMACEUTICALS, INC.	2 years
Steven Ryder	M	73	REATA PHARMACEUTICALS, INC.	1 years
Colin Meyer	M	45	REATA PHARMACEUTICALS, INC.	20 years
Christy Oliger	F	54	REATA PHARMACEUTICALS, INC.	2 years
Richard McGaughy	M	52	REATA PHARMACEUTICALS, INC.	19 years
Martin Edwards	M	68	REATA PHARMACEUTICALS, INC.	3 years
Jack Nielsen	M	60	REATA PHARMACEUTICALS, INC.	16 years
William Rose	M	56	REATA PHARMACEUTICALS, INC.	7 years
William McClellan	M	64	REATA PHARMACEUTICALS, INC.	6 years
Kevin Johnston	M	-	REATA PHARMACEUTICALS, INC.	2 years
Elaine Castellanos	F	-	REATA PHARMACEUTICALS, INC.	13 years
Rajiv Patni	M	55	REATA PHARMACEUTICALS, INC.	-
Elizabeth Messersmith	M	-	Quark Pharmaceuticals, Inc. Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.	2 years
Michael Wortley	M	76	REATA PHARMACEUTICALS, INC.	8 years
Andrea Loewen-Rodriguez	F	57	REATA PHARMACEUTICALS, INC.	3 years
Dawn Bir	F	53	REATA PHARMACEUTICALS, INC.	7 years
Oscar Sanchez	M	-	REATA PHARMACEUTICALS, INC.	2 years
Claudia Bujold	F	-	REATA PHARMACEUTICALS, INC.	4 years
Steve Harman	M	-	REATA PHARMACEUTICALS, INC.	4 years
Edmund Doherty	M	-	REATA PHARMACEUTICALS, INC.	11 years
Masa Tanaka	M	-	Quark Pharmaceuticals, Inc. Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.	3 years
Dakota Gallivan	M	-	REATA PHARMACEUTICALS, INC.	3 years
Jan Reene	F	-	REATA PHARMACEUTICALS, INC.	3 years
Bhaskar Anand	M	46	REATA PHARMACEUTICALS, INC.	2 years

Statistics

Country	Connections	% of total
United States	34	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections